The Role of Resveratrol in Modulating Neuroinflammation in Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Cerebral Ischemia - Summary - MDSpire
Advertisement
The Role of Resveratrol in Modulating Neuroinflammation in Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Cerebral Ischemia
To examine the potential effects of resveratrol (RES) on memory-related processes and neuroinflammatory biomarkers specifically in major neurological disorders.
Key Findings:
RES can modulate biological pathways associated with neurodegeneration, including oxidative stress, inflammatory signaling, mitochondrial dysfunction, and blood-brain barrier disruption.
In preclinical models of AD and PD, RES is linked to cognitive performance improvements and reduced neuroinflammatory markers.
Studies in MS and cerebral ischemia models show that RES may modulate immune responses and limit neuronal injury.
Interpretation:
Experimental findings support the potential neuroprotective role of RES, but clinical data are limited and further well-designed studies are needed to validate these findings.
Limitations:
Most evidence is derived from in vitro and animal studies.
Limited clinical data on the effects of RES in humans.
Low bioavailability of RES and variability in dosing regimens pose challenges for clinical application.
Standardized dosing regimens are needed for clinical studies.
Conclusion:
Continued investigation of RES is warranted as a promising candidate for neuroprotective strategies in neurological disorders.
